Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01000350 · ClinicalTrials.gov registry record · NA

Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)

A NA study of Postural Tachycardia Syndrome, sponsored by Vanderbilt University Medical Center.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT01000350 is a NA study of Postural Tachycardia Syndrome that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 40 participants, below the 81-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01000350, a NA study of Postural Tachycardia Syndrome, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The investigators will test whether an intravenous infusion of saline (salt water) will improve the exercise capacity in patients with postural tachycardia syndrome (POTS).

Interventions

  • OTHER Placebo
  • DRUG Saline

Study Locations (1)

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2009-10
Est. Completion 2028-06
Phase NA

What the Registry Record Tells You About NCT01000350

The ClinicalTrials.gov registry entry for NCT01000350 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 81-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (51% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postural Tachycardia Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01000350 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT01000350 about?

NCT01000350 is a clinical study titled "Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)". The investigators will test whether an intravenous infusion of saline (salt water) will improve the exercise capacity in patients with postural tachycardia syndrome (POTS).

What is the current status of trial NCT01000350?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2009-10. Estimated completion is 2028-06.

What conditions does trial NCT01000350 study?

This clinical trial studies the following conditions: Postural Tachycardia Syndrome.

What interventions are being tested in trial NCT01000350?

The interventions under investigation include: Placebo (OTHER), Saline (DRUG).

Who is sponsoring clinical trial NCT01000350?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01000350 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postural Tachycardia Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.